JOINING A PHARMACEUTICAL COMPANY AS THE HEAD OF A CANCER RESEARCH
LABORATORY
Claudia GonçalvesAmanda KamarLoïc Gauthier
Hala Zahaf
Genova – 26 July 2013
WHY?
Global impact International
opportunities State-of-the-art
equipment Highly-qualified team Focus on particular
project Stability, security
ESTIMATED NUMBER OF NEW CANCER CASES BY WORLD AREA
Source: Globocon, 2008
Country Million € Employment (Units)United Kingdom 5,588 65,000Germany 5,318 105,435Switzerland 4,972 38,561France 4,787 103,900Belgium 1,907 32,167Italy 1,250 65,000Denmark 1,102 20,223
RESEARCH AND DEVELOPMENT IN EUROPE
In total:
€ 30,000 million invested in R&D in Europe 700,000 people employed (116,000 in R&D)
TOP 10 PHARMACEUTICAL COMPANIES
Company Country Billions (USD)1. Pfizer USA 50.22. Novartis Switzerland 45.73. Merck&Co USA 35.54. Sanofi-Aventis France 34.75. AstraZeneca UK 32.86. Roche Switzerland 30.47. GlaxoSmithKline UK 30.18. Johnson&Johnson USA 24.59. Abbott USA 22.610. Lilly USA 21.3
EUROPEAN PHARMACEUTICAL LEADERS
World leader in diagnostic research for cancer
Employs 82,029 people (2012) 22% work in R&D
#1 investor in R&D - high turnover (2011)
World leader in biomedical research
Employs 127,724 people (2012) 48% work in R&D
6.7 billion USD spent on R&D in 2012
Roche Novartis
WHERE?
New indications in the pipeline
Phase I (27), Phase II (18), Phase III (30)
AVASTIN® (3,47 billions € turnover)
7 R&D centers in Europe
8 new molecules (oncology) in the pipeline
3 new indications for AFINITOR® (2,5 billions € turnover)
7 R&D centers in Europe
HEAD OF ANTI-CANCER DRUG RESEARCH LABORATORY
Requirements:
PhD and Post-doc in chemistry or life science required
Minimum 15 years of relevant industry experience.
Strong leadership & communication skills
Novartis Institutes for BioMedical Research (NIBR)
THE ROAD TO THE TOP…
HOW? Show added value!
CV – PhD, Postdoc, international studies, technical skills, multilingual
Cover letter – knowledge of company, research experience, interest in the position
Email or call a contact
Interview – focus on body language and communication
PRINCIPAL CONTACTS Sylvie Dejager
Novartis Pharma SAS [email protected] Principal Medical and Scientific Expert
(Researcher) PhD – Molecular Biology and Endrocinology
Niclas Hitziger Roche Diagnostics [email protected] International Product Manager
Previously Senior Team Leader and Group Leader PhD & Postdoc – Molecular Biology
THE VISION Impact global health issues – especially
cancer Opportunity to participate in growing market Train other people from developing countries
and contribute to the spread of the knowledge
ACKNOWLEDGEMENT Sandrine Lacombe Mario Rocca Nicolas Rabasso Ivan Coste-Maniere Giorgio Musso Ryszard Naskręcki Dorota Piontek Schanzenbach Dirk Bohdan Skalski Carlos Perreira
Research Scientist
Group
Leader
Senior Team Leade
r
Product
Manager
Current Job Offers Research Investigator in Oncology (Novartis)
Supervise 2-3 associates PhD in life science required Strong leadership & communication skills
Senior Scientist for Discovery Oncology (Roche) “developing a mechanistic understanding of tumor cell
sensitivity and resistance to molecularly-targeted anti-cancer agents”
PhD and Post-doc experience required Outstanding written & oral communication skills